Abstract: Six, clinically healthy horses, of mixed age and sex, were infused via a jugular venous catheter with 100 ml of pyrogenfree sterile saline (PFSS; 0.9% NaCl). Animals were infused with Escherichia coli O55:B5 endotoxin (total dose = 50 ng/kg bwt), 24 (LPS-1) and 48 h (LPS-2) after PFSS infusion. Blood was collected before, and every 15 min after, each infusion for the first 8 h and then every 2 h for the following 14 h. Clinical responses (rectal temperature, heart rate, respiration rate and blood pressure) were determined before and every 4 h after each infusion for 20 h. Geometric mean anti-endotoxin antibody titres in serum samples, harvested just before each infusion, were unchanged over the course of the experiment. Serum tumour necrosis factor-alpha (TNF alpha) activity was estimated using a cytotoxic bioassay and WEHI 164 clone 13 murine fibrosarcoma cells as targets. Mean clinical parameter values and geometric mean serum TNF alpha activity at given time points were compared across the 3 infusions. Both LPS-1 and LPS-2 resulted in elevated mean rectal temperature at 4 h after infusion. However, duration of mean rectal temperature elevation was greater (P < 0.05) after LPS-1 (through 12 h) than after LPS-2 (through 8 h). More substantial increases in systolic and diastolic blood pressure were observed after LPS-1 than LPS-2 and mean systolic blood pressure after LPS-1 was elevated at 4 h when compared to PFSS (P < 0.05). Decreased systolic and diastolic blood pressures were observed at 16 h after both LPS infusions, when compared to PFSS infusion. Heart rate was increased, compared to PFSS, after both LPS-1 (8-12 h) and LPS-2 (4-12 h) (P < 0.05). No significant elevations in mean respiratory rate were observed after either LPS-1 or LPS-2 when compared to PFSS. However, at 4 h post infusion, mean respiratory rate after LPS-2 was greater (P < 0.05) than that after LPS-1. Serum TNF alpha activity was not detected after infusion of PFSS, but was detected after both LPS-1 and LPS-2. Serum TNF alpha activity was elevated earlier, was present in higher concentrations and persisted longer after LPS-1 than after LPS-2 (P < 0.05). The decreased duration of fever and attenuated serum TNF alpha response subsequent to successive sublethal LPS challenge observed in this study support the conclusion that these horses developed early-phase endotoxin tolerance (EPET) and, therefore, contributes to the understanding of the role of endotoxaemia in a number of clinical conditions in horses.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This study investigates the development of early-phase endotoxin tolerance in horses to understand endotoxaemia’s role in various equine health conditions. The research involved the introduction of sublethal doses of E. coli O55:B5 endotoxin to six healthy horses, observing alterations in clinical responses and serum tumour necrosis factor-alpha (TNF-α) activity.
Overview of the Research Procedure
Six horses were infused with 100 ml of pyrogen-free sterile saline (PFSS), followed by Escherichia coli O55:B5 endotoxin at 24 hours and 48 hours afterward.
Blood samples were collected at regular intervals after each infusion to track changes in the horses’ physiological status.
Clinical responses, including rectal temperature, heart rate, respiration rate, and blood pressure, were recorded before and each 4 hours after the infusions for 20 hours.
Findings of the Study
Infusing Escherichia coli O55:B5 endotoxin led to a rise in the average rectal temperature of the horses four hours after both infusions. However, this temperature elevation lasted longer after the first infusion (LPS-1) and lessened by the second infusion (LPS-2).
LPS-1 caused more significant increases in systolic and diastolic blood pressure compared to LPS-2.
The heart rate was observed to rise post the LPS-1 and LPS-2 compared to PFSS.
There were no significant changes recorded in mean respiratory rate after either the LPS-1 or LPS-2 compared to PFSS, but after four hours post infusion, the average respiratory rate was higher with LPS-2 than LPS-1.
After administering PFSS, serum TNF-α activity wasn’t detected but surfaced after both LPS-1 and LPS-2. The activity was present sooner, in higher concentrations, and lasted longer after the LPS-1 injection.
Conclusion
The variation in clinical parameters and TNF-α activity suggests that the horses developed an early-phase endotoxin tolerance after the successive LPS challenge.
The insights obtained from this study contribute to understanding the role of endotoxaemia in various clinical conditions in horses.
Cite This Article
APA
Allen GK, Campbell-Beggs C, Robinson JA, Johnson PJ, Green EM.
(1996).
Induction of early-phase endotoxin tolerance in horses.
Equine Vet J, 28(4), 269-274.
https://doi.org/10.1111/j.2042-3306.1996.tb03090.x